New York University School of Medicine, Dept of Population Health
New York, 10016, United States
NCT Number: NCT02041598
The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC).
Looking for future studies?
Notify Me25 year–85 year
All sexes
Interventional
Not applicable
New York, 10016, United States
The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC). For a two-arm, randomized controlled trial (RCT), investigators will recruit a sample of 256 participants, all of whom are 1) of Bangladeshi descent, 2) residing in NYC, 3) diagnosed with Type 2 diabetes mellitus (T2DM) and a recent Hemoglobin A1c (HbA1c) of ≥ 6.5, and 4) between the ages of 21-85. The treatment group receives a six-month CHW-led intervention consisting of five monthly group educational sessions, two one-on-one visits, and follow-up phone calls as needed from a CHW. The control group receives an introductory educational session only. Primary and secondary outcomes include clinical and behavioral measures, such as HbA1c and weight change, access to and utilization of care (i.e. appointment keeping and use of specialty care), and knowledge and practice of physical activity and healthful eating. Additionally, information regarding CHW characteristics, the processes and mechanisms for influencing healthful behavior change, and fidelity of the intervention are collected. Outcomes are measured at Baseline, 3-Months, 6-Months for both groups, and at 12-Months for the treatment group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5 group educational sessions, 2 1v1 Visits with a CHW, Phone Calls as needed during 6-month study period
Time frame: Baseline, 6-Months
Change in Baseline HbA1c at 6-Months
Time frame: Baseline, 6-Months
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
Time frame: Baseline, 6-Months
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
Time frame: Baseline, 6-Months
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
Time frame: Baseline, 6-Months
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
Time frame: Baseline, 6-Months
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
Time frame: Baseline, 6-Months
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
Time frame: Baseline, 6-Months
HDL, LDL, Triglycerides, Total Cholesterol
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05259449
Diabetes Mellitus, Diabetes Mellitus, Type 2
Puerto Real, Cadiz, Spain
View Trial DetailsNCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT07251504
Diabetes Mellitus, Diabetes Mellitus, Type 2
Puerto Real, Cádiz, Spain
View Trial DetailsNCT00445627
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial Details